Navigation Links
Longitudinal Study Highlights Evolving Role of Medical Science Liaisons with Thought Leaders and Product Development
Date:3/1/2013

CHAPEL HILL, N.C., March 1, 2013 /PRNewswire/ -- While medical science liaisons have been around for more than 40 years, the role and activities of these medical specialists have grown quickly over the last decade. The pharmaceutical industry has long relied on medical science liaisons to forge relationships with key opinion leaders (KOLs) who can provide critical insights into the market and competition.

But the changing regulatory and access environment has altered the landscape for creating and maintaining KOL and physician relationships.

To help organizations navigate this new KOL landscape, research and consulting leader Best Practices LLC published a MSL-focused report that highlights their key pre- and post-launch activities, and service frequencies. The 78-page report presents 2011 data compared to 2009 on an array of critical activities that provide insights into how MSLs can build strong, productive relationships with KOLs and physicians. 

"Roles, Resourcing and Management of Medical Science Liaisons" provides MSL leaders with key metrics to help them create and maintain an effective MSL group. The comparative structure of the report (2011 data vs. 2009 data) also opens a window to emerging trends that will enable leaders in medical affairs – the group where MSL operations are typically housed - to set a clear direction for their MSL group going forward.

For instance, the study shows companies in 2011 were having managers oversee a greater number of MSLs than they did in 2009. In 2011, 57 percent of respondents preferred to have one manager overseeing 7-10 specialists. In 2009, the preferred span-of-control was one manger to up to six specialists (47 percent).

The key topics covered in this report include:

  • Benchmark Pre and Post-Launch Service Activities
  • Identify Drivers of Group Size & Focus
  • Gain insight into Structuring & Aligning Medical With Sales Organizations
  • Identify Optimal Call Frequencies and Service Levels with Thought Leaders
  • Identify Relationship Management Standards of Excellence
  • Value Associated with MSL
  • Budget Allocation to MSLs

The research project included observations and insights from 27 leaders with 24 companies, including 10 of the Top 20 pharma organizations. To learn more about this report, download a complimentary excerpt at http://www3.best-in-class.com/rr1205.htm.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Study Shows Cannabis Effects on Driving Skills
2. Independent Study Published in Clinical Infectious Diseases Highlights the Importance of Antimicrobial Removal Systems in Blood Culture to Rapidly and Accurately Aid in the Diagnosis of Sepsis
3. University Hospitals Case Medical Center Presents Study On The Elimination Of Retained Surgical Sponges
4. MD+DI, the Global MedTech Authority, Publishes One-of-a-Kind Study with ITG Market Research on the Medical Device Outsourcing Landscape
5. New Direct-to-Consumer Prescription Delivery Channel Mitigates Risk of Medication Non-Adherence Highlighted in JAMA Internal Medicine Study
6. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma Data from KB002 Phase 1/2 Study Presented at the American Academy of Allergy, Asthma and Immunology Meeting
7. Study Shows Medicare Savings When Local Pharmacies Fill 90-Day Prescriptions
8. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
9. Adynxx Enrolls First Patient in Phase 2 Proof-of-Concept Study for AYX1, Lead Compound for the Prevention of Post-Surgical Pain
10. First U.S. Patients Treated in PneumRx RENEW Pivotal Study for Treatment of Severe Emphysema
11. New Study Results Published in the New England Journal of Medicine Show Dabigatran Etexilate Mesylate Reduces the Risk of Recurrent Venous Thromboembolism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 2016 , Net Sales of $1.90 billion ... the prior year period, and an increase of 1.2% on ... EPS for the first quarter were $0.52 reported, a decrease ... an increase of 29.9% over the prior year period ... guidance for 2016 Zimmer Biomet Holdings, Inc. (NYSE ...
(Date:4/28/2016)... N.J. , April 28, 2016   Acsis ... today announced that leading IT market research and advisory ... " in the IDC MarketScape: Worldwide Pharmaceutical Track and ... 2016).  The report provides an assessment of the capabilities ... track and trace software market. Logo - ...
(Date:4/28/2016)... 28, 2016 New market ... is a report that provides an overview of ... pipelines by identifying new targets and MOAs to ... Profiles discussed in this H1 2016 Osteoarthritis Pipeline ... AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, Achelios ...
Breaking Medicine Technology:
(Date:4/30/2016)... Indianapolis, Indiana (PRWEB) , ... April 30, 2016 , ... ... USA Wrestling as they go for gold in Rio. Under the care of ... including two golds! , In an unprecedented showing, Maximized Living is sending the largest ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... the Accreditation Council for Graduate Medical Education (ACGME) that it has received accreditation ... the first accreditation of three residency programs that Memorial is currently pursuing, including ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... and author of best seller "LOVE, MEDICINE and MIRACLES") addresses touchy topics related ... 2016 and podcasted thereafter . Dr. Bernie Siegel, author of a plethora ...
(Date:4/29/2016)... ... April 29, 2016 , ... Spine Team Texas, a ... proud to announce one of their physicians has been invited to be a featured ... ACOFP) Family Practice Review conference on April 30, 2016. , Dr. R. Scott ...
(Date:4/29/2016)... ... ... the deadliest type of skin cancer. Although only about 1 percent of skin cancer cases ... 10,000 people are expected to die of melanoma this year. The risk increases with age, ... most commonly diagnosed cancers in young women. A recent breakthrough in genetic studies may give ...
Breaking Medicine News(10 mins):